Rua Bioscience Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
24
- Stock Symbol
-
RUA
- Investments
-
1
- Share Price
-
$0.01
- (As of Tuesday Closing)
Rua Bioscience General Information
Description
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, with its primary business being research and development and the sale of pharmaceutical products in New Zealand, Australia, and Europe.
Contact Information
Website
www.ruabio.comCorporate Office
- Gisborne
- New Zealand
Corporate Office
- Gisborne
- New Zealand
Rua Bioscience Stock Performance
As of 17-Nov-2026, Rua Bioscience’s stock price is $0.01. Its current market cap is $5.42M with 379M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.01 | $0.01 | $0.01 - $0.02 | $5.42M | 379M | 87.6K |
Rua Bioscience Financials Summary
As of 30-Jun-2026, Rua Bioscience has a trailing 12-month revenue of $1.51M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 5,170 | 5,170 | 4,035 | 3,341 |
| Revenue | 1,509 | 1,509 | 890 | 52 |
| EBITDA | (1,559) | (1,559) | (1,704) | (8,139) |
| Net Income | (1,964) | (1,964) | (2,034) | (8,315) |
| Total Assets | 4,052 | 4,052 | 4,115 | 4,711 |
| Total Debt | 992 | 992 | 488 | 90 |
Rua Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rua Bioscience Signals
Rua Bioscience Acquisitions (1)
Rua Bioscience’s most recent deal was a Merger/Acquisition with Zalm Therapeutics for . The deal was made on 19-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Zalm Therapeutics | 19-Jan-2022 | Merger/Acquisition | Personal Products |
Rua Bioscience ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Traders & Distributors
Industry
Rank
Percentile
Trading and Distribution
Subindustry
Rank
Percentile
Rua Bioscience FAQs
-
When was Rua Bioscience founded?
Rua Bioscience was founded in 2016.
-
Where is Rua Bioscience headquartered?
Rua Bioscience is headquartered in Gisborne, New Zealand.
-
What is the size of Rua Bioscience?
Rua Bioscience has 24 total employees.
-
What industry is Rua Bioscience in?
Rua Bioscience’s primary industry is Drug Discovery.
-
Is Rua Bioscience a private or public company?
Rua Bioscience is a Public company.
-
What is Rua Bioscience’s stock symbol?
The ticker symbol for Rua Bioscience is RUA.
-
What is the current stock price of Rua Bioscience?
As of 17-Nov-2026 the stock price of Rua Bioscience is $0.01.
-
What is the current market cap of Rua Bioscience?
The current market capitalization of Rua Bioscience is $5.42M.
-
What is Rua Bioscience’s current revenue?
The trailing twelve month revenue for Rua Bioscience is $1.51M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process